V.F.Snegirev Archives of Obstetrics and GynecologyV.F.Snegirev Archives of Obstetrics and Gynecology2313-87262687-1386Eco-Vector3547610.18821/2313-8726-2018-5-4-213-221Research ArticleGENETIC MARKERS OF METABOLIC DISORDERS AFTER RADICAL HYSTERECTOMY AND OOPHORECTOMYGinzburgE. B-SosnovaElena A.MD, PhD, DSci., Professor of the Department of Obstetrics and Gynecology, Medical Faculty No 1 of the I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation.sosnova-elena@inbox.ruTumbinskayaL. V-Kaluga Regional Clinical HospitalI.M. Sechenov First Moscow State Medical UniversityClinic of Innovative Technologies151220185421322121072020Copyright © 2018, Eco-Vector2018In 38 operated patients with benign uterine diseases, represented by such isolated forms as endometrial hyperplasia, uterine myomas and adenomyosis, as well as their combination, a clinical assessment of the quantitative indices of fat metabolism disorders, such as the average value of the body mass index (BMI) before treatment, 3, 6 and 12 months after surgery, as well as changes in blood pressure (BP). Clinical and laboratory analysis and analysis of genetic markers made it possible to identify alleles of high risk of arterial hypertension, as well as disorders of fat metabolism and the formation of metabolic syndrome (MS), to conclude that the identified candidate alleles allow predicting changes in BMI, BP and to form risk groups, to take preventive measures to prevent the formation of complications such as diabetes, myocardial infarction and stroke in overweight patients who have undergone surgery. The aim of the work is to identify prognostically significant genetic markers for the development of arterial hypertension, disorders of fat metabolism, and MS after subtotal hysterectomy. Material and methods. There were examined 38 patients after subtotal hysterectomy with bilateral adnexectomy or without it. Within 12 months after surgery, changes in BMI and systolic BP were observed in dynamics. The polymorphism of the following genes was studied in all patients in the studied groups: s.388T> C and p.526 C> T in the ApoE gene, pp. 306-109-2306-108insA288 in the ACE gene, p.176T> C in the IGBT3 gene. DNA samples obtained by the method of phenol-chloroform extraction from 10 ml of whole venous blood served as the material for the study of polymorphisms. Analysis of single nucleotide polymorphisms of genes (SNP) was performed by the method of minisequencing followed by mass spectrometric fractionation of oligonucleotide probes using time-of-flight (MALDI-TOF) mass spectrometry. Results. Specific alleles of the ACE and ApoE genes, characteristic of a high risk of developing hypertension, as well as prognostically significant candidate alleles of MS development, and the likelihood of impaired fat metabolism were established.adnexectomybody mass index (BMI)risk allelesmetabolic syndromearterial hypertensionviolation of fat metabolismаднексэктомияиндекс массы тела (ИМТ)аллели рискаметаболический синдромартериальная гипертензиянарушение жирового обмена[Синицын П.А., Порядина Г.И., Хмырова А.П., Петряйкина Е.Е., Пронина Л.А., Щербакова М.Ю., Ларионова В.И. Метаболический синдром у детей и подростков. Клинико-генетические параллели. Артериальная гипертензия. 2010; 16 (5): 479-83.][Perical-Vance M.A., Bebout J.L., Haynes C.A., Gaskell P.C., Yamaoka L.H., Hung W.Y. et al. Linkage studies in familial Alzheimer’s disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 1990; 47 (Suppl.): A194.][Felker Т., Fainaru R., Hamilton R., Havel R. Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver. J. Lipid Res. 1977; 18: 465-73.][Rivera C.M., Grossardt B.R. et. al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009; 16:15-23.][Мяндина Г.И., Зотова Т.Ю., Вареха Л.А., Касапова Е.Н. Полиморфизмы генов ITGB3 и протромбина среди пациентов с дислипидемиями, страдающих гипертонической болезнью и ишемической болезнью сердца. Здоровье и образование в ХХI веке. 2014; 16 (4): 56-9.][Зотова Т.Ю., Азова М.М., Аисса А.А., Гигани О.О., Фролов В.А. Анализ полиморфизмов генов ангиотензиновой системы (ACE, AGTR1, AGT) и гена ITGB3 у пациентов с артериальной гипертензией в сочетании с метаболическим синдромом. Бюл. эксперим. биол. и мед. 2016; 161 (3): 308-12.][Муслимова Э.Ф., Реброва Т.Ю., Серебрякова В.Н., Афанасьев С.А., Трубачева И.А. Ассоциация полиморфизмов генов ACE, NOS3, ITGB3 И P2RY12 с уровнем общего холестерина и глюкозы у женщин трудоспособного возраста Западно-Сибирского региона. Дальневост. мед. журн. 2015; (2): 79-83.][Weiss L.A., Abney M., Parry R. et al. Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample. Hum. Genet. 2005; 117; 81-7.][Tofteng C.L., Bach-Mortensen P., Bojesen S.E., Tybjaerg-Hansen A., Hyldstrup L., Nordestgaard B.G. Integrin beta-3 leu33-to-pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population. Pharmacogenet. Genomics. 2007; 17: 85-91.][Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human Angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase1). Nucleic Acid Research. 1992; 20:1433.][Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion /deletaion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86 (4): 1343-6.][Dijk M.A., Kroon I., Kamper A.M. et al. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. J. Cardiovasc. Pharmacol. 2000; 35 (3): 484-90.][Моисеев В.С., Демуров Л.М., Кобалава Ж.Д., Чистяков Д.А., Терещенко С.Н., Кондратьев Я.Ю. и др. Полиморфизм гена ангиотензинпревращающего фермента у пациентов с гипертонической болезнью, гипертрофией левого желудочка и развитием инфаркта миокарда в молодом возрасте. Тер. архив. 1997; 69 (9): 18-33.][Bell D.M., Rutledge D.R., Pepine C.J. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and angiotensin-converting enzyme inhibitor cough in patients with congestive heart failure. In: Abstracts of the 19-th Congress of the European Society of Cardiology. Stockholm; 1997: 976.][Glavnik N., Petrovic D. M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hy-pertension in Caucasians. Folia Biol. (Praha). 2007; 53 (2): 69-70.][Целуйко В.И., Бригвадзе Т.З., Мищук Н.Е., Вашакидзе З.С. Полиморфизм гена рецептора ангиотензина II 1-го типа и его влияние на эффективность терапии олмесартаном у пациентов с гипертонической болезнью. Укр. кардиол. журн. 2013; (4): 21-7.][Kojima S., Inenaga T., Matsuoka H. et al. The association between salt sensitivity of blood pressure and some polymorphic factors. J. Hypertens. 1994; 12 (7): 797-801.][Staessen J.A., Wang J.G., Ginocchio G., et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J. Hypertens. 1997; 15(12 Pt 2):1579-92.][Sunder-Plassmann G., Kittler H., Eberle C. et al. Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit. Care Med. 2002; 30 (10): 2236-41.][Morshed M., Khan H., Akhteruzzaman S. Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J. Biochem. Mol. Biol. 2002; 35 (3): 251-4.][Бабак О.Я., Кравченко Н.А. Роль ренин-ангиотензиновой системы в ремоделировании сердца и сосудов. Укр. терапевт. журн. 2005; (2): 89-96.][Papp F., Friedman A.L., Bereczki C. et al. Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr. Nephrol. 2003; 18: 150-4.][Celik A., Diler S.B. Assessment of genetic damage in buccal epithelium cells of painters: micronucleus, nuclear changes, and repair index. DNA Cell Biol. 2010; 29 (6): 277-84.][Березнева Н.А., Аверьянова Н.С., Громыко О.Е., Асанов А.Ю., Басаргина Е.Н., Пинелис В.Г. Полиморфизмы генов ренин-ангиотензиновой системы при дилатационной кардиомиопатии у детей. Рос. педиатр. журн. 2012; (3): 14-9.][Takahashi T., Yamaguchi E., Furuya K. et al. The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage. Respir. Med. 2001; 95 (2): 130-5.][Вейр Б. Анализ генетических данных. М.: Мир; 1995.]